Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection

Annals of Surgical Oncology

Volumn 10, Issue 3, 2003, Pages 213-218

  Joseph, Natalie E ^a   Sigurdson, Elin R ^a,b   Hanlon, Alexandra L ^b   Wang, Hao ^b   Mayer, Robert J ^c   MacDonald, John S ^d   Catalano, Paul J ^e   Haller, Daniel G ^f  

^a Department of Surgical Oncology ^*  (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c Cancer and Leukemia Group B   (United States)

^d Southwest Oncology Group   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f Eastern Cooperative Oncology Group   (United States)

Author keywords

5 fluorouracil chemotherapy; Colon cancer; Lymph node status; Prognostic factors; Survival

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE;

ACCURACY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEMICOLECTOMY; HIGH RISK POPULATION; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PREDICTION; ADJUVANT CHEMOTHERAPY; ADULT; AGED; COLON RESECTION; COLON TUMOR; FOLLOW UP; LYMPHADENECTOMY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; THEORETICAL MODEL;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASM STAGING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0038472209     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2003.03.059     Document Type: Article

References (24)

1. Hermanek P. pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg 1995;19: 184-90.
2. Moertel CG. Chemotherapy for colorectal cancer. N Engl J Med 1994;330:1136-42.
3. O'Connell MJ. North Central Cancer Treatment Group - Mayo Clinic trials in colon cancer. Semin Oncol 2001;28:4-8.
4. O'Connell MJ, Maillard JA, Kahn MJ, et al. Controlled trial of fluorouracil and low dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997; 15:246-50.
5. Hernanz F, Revuelta S, Redondo C, et al. Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum 1994;37:373-7.
6. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma: trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996; 106:209-16.
7. Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 1999;17:2896-900.
8. Reinbach DH, McGregor JR, Murray GD, O'Dwyer PJ. Effect of the surgeon's specialty interest on the type of resection performed for colorectal cancer. Dis Colon Rectum 1994;37:1020-3.
9. Scott KWM, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 1989;76:1165-7.
10. Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992;69:2496-501.
11. Herrera-Ornelas L. Metastases in small lymph nodes from colon cancer. Arch Surg 1987;122:1253-6.
12. Cohen AM, Kelsen D, Saltz L, et al. Adjuvant therapy for colorectal cancer. Curr Probl Cancer 1998;22:5-65.
13. Liefers G, Cleton-Jansen A, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-8.
14. Giacomantonia CA, Temple WJ. Quality of cancer surgery: challenges and controversies. Surg Oncol Clin North Am 2000;9:51-60.
15. Saettler EB, Temple WJ. The surgeon as a prognostic factor in the management of pancreatic cancer. Surg Oncol Clin North Am 2000;9:133-42.
16. Hartgrink HH, Bonenkamp HJ, van de Velde CJH. Influences of surgery on outcomes in gastric cancer. Surg Oncol Clin North Am 2000;9:97-117.
17. Hida J, Mori N, Kubo R, et al. Metastases from carcinoma of the colon and rectum detected in small lymph nodes by the clearing method. J Am Coll Surg 1994;178:223-8.
18. Rodriguez-Bigas MA, Maamoun S, Weber TK, et al. Clinical significance of colorectal cancer: metastases in lymph nodes <5 mm in size. Ann Surg Oncol 1996;3:124-30.
19. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed. A secondary survey of INT-0089 (abstract). Proc Am Soc Clin Oncol 2000;925.
20. Tepper JE, O'Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001;19:157-63.
21. Esser S, Reilly WT, Riley LB, et al. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum 2001;44:850-6.
22. Paramo JC, Summerall J, Wilson C, et al. Intraoperative sentinel lymph node mapping in patients with colon cancer. Am J Surg 2001;182:40-3.
23. Bendavid Y, Latulippe JF, Younan RJ, et al. Phase I study on sentinel lymph node mapping in colon cancer: a preliminary report. J Surg Oncol 2002;79:81-4.
24. Tsioulias GJ, Wood TF, Morton DL, et al. Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms. Arch Surg 2000;135:926-32.